Invention Grant
US09023804B2 HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
有权
衍生自前列腺相关抗原分子的HLA结合肽及其使用方法
- Patent Title: HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
- Patent Title (中): 衍生自前列腺相关抗原分子的HLA结合肽及其使用方法
-
Application No.: US13993291Application Date: 2011-11-14
-
Publication No.: US09023804B2Publication Date: 2015-05-05
- Inventor: Toni Weinschenk , Peter Lewandrowski , Hans Georg Rammensee , Stefan Stevanovic , Cecile Gouttefangeas
- Applicant: Toni Weinschenk , Peter Lewandrowski , Hans Georg Rammensee , Stefan Stevanovic , Cecile Gouttefangeas
- Applicant Address: DE Tuebingen
- Assignee: Immatics Biotechnologies GmbH
- Current Assignee: Immatics Biotechnologies GmbH
- Current Assignee Address: DE Tuebingen
- Agency: Miles & Stockbridge PC
- Priority: WOPCT/EP2010/069675 20101214
- International Application: PCT/EP2011/070024 WO 20111114
- International Announcement: WO2012/079878 WO 20120621
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K39/00 ; C12N9/64 ; A61K45/06
Abstract:
Methods and compositions for immunotherapeutic treatment of prostate cancer are disclosed. More specifically methods of treating patients with prostate cancer comprising administering compositions comprising HLA-binding peptides derived from prostate-associated antigenic molecules, either with or without immunological adjuvants, are disclosed.
Public/Granted literature
- US20130336922A1 HLA-BINDING PEPTIDES DERIVED FROM PROSTATE-ASSOCIATED ANTIGENIC MOLECULES AND METHODS OF USE THEREOF Public/Granted day:2013-12-19
Information query
IPC分类:
